Equity Overview
Price & Market Data
Price: $0.101
Daily Change: +$0.00165 / 1.63%
Range: $0.101 - $0.103
Market Cap: $17,161,062
Volume: 1,770
Performance Metrics
1 Week: 5.81%
1 Month: -23.22%
3 Months: 45.99%
6 Months: -1.42%
1 Year: -34.22%
YTD: 25.06%
Details
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers. The company also provides VMS+ software, a 2D and 3D ultrasound models. In addition, it develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging, and cardiotoxicity in oncology patients. Ventripoint Diagnostics Ltd. is headquartered in Toronto, Canada.